With this approach, we identified five important master regulators that are plausible drivers of short survival in GBM: IGFBP2, VEGFA/VEGF165, platelet-derived growth factor A (PDGFA), AEBP1, and OSMR. This evidence concerns the gene IGFBP2 and glioblastoma.